Monday, October 10, 2016

Maalox Plus Suspension







Maalox plus




Contents:


500 ml Suspension


Contains the equivalent of Dried Aluminium Hydroxide Gel 220 mg, Magnesium Hydroxide 195 mg and
Simeticone 25 mg in each 5 ml.


Also contains: methylparaben, propylparaben, micro-crystalline cellulose, sodium carboxymethylcellulose, methylcellulose, hydroxypropylcellulose, hydrogen
peroxide, citric acid, sodium saccharin, sorbitol, natural lemon concentrate, swiss creme flavour and water.


Maalox Plus is an antacid which relieves symptoms by neutralising stomach acid and has an antifoaming agent which aids removal of gas.





MA Holder:



sanofi-aventis

One Onslow Street

Guildford

Surrey

GU1 4YS

UK




Manufactured by



sanofi-aventis S.p.A.

Viale Europa

11 - Origgio (VA)

Italy





For:


symptomatic relief of dyspepsia (indigestion), heartburn and flatulence (wind).



Do not take if you are allergic to any of the active and other ingredients, you are feeling severely debilitated or suffer from kidney disease or hypophosphataemia.



Ask your Pharmacist or Doctor before taking Maalox Plus if you are taking any other
medicines or you are pregnant or breast feeding.


Maalox Plus should not be taken at the same time as other medicines, as Maalox Plus may interfere with the absorption if taken within one hour.




Directions:


adults including elderly persons: take one to two 5 ml spoonfuls 20 minutes to 1 hour after meals and at bedtime or as required.


Children: an appropriate proportion of the adult dose.


Children under 5 years old: not more than one 5ml spoonful three times a day.


If symptoms persist consult your doctor.


Contact your doctor immediately if too much is taken.


SHAKE WELL BEFORE USE.




Side Effects:


constipation or diarrhoea can occur but these effects are not common.


Tell your doctor or pharmacist if you notice any other unwanted effects.


Use by the date given on the label below.


Do not allow this product to freeze.


Remember to keep all medicines safely away from children.



Information revised: January 2007


PL5272/0020






No comments:

Post a Comment